Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Dl-Alpha-Methoxyphenylacetic Acid

    • Product Name Dl-Alpha-Methoxyphenylacetic Acid
    • Alias DL-α-MPAA
    • Einecs 242-318-8
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    447733

    Name Dl-Alpha-Methoxyphenylacetic Acid
    Synonyms DL-α-Methoxyphenylacetic acid, DL-2-Methoxy-2-phenylacetic acid
    Cas Number 1667-09-4
    Molecular Formula C9H10O3
    Molecular Weight 166.18 g/mol
    Appearance White to off-white crystalline powder
    Melting Point 105-108°C
    Solubility Slightly soluble in water, soluble in ethanol and ether
    Density 1.215 g/cm³
    Storage Conditions Store in a cool, dry place and keep container tightly closed
    Purity Typically ≥98%
    Smiles COC(C(=O)O)C1=CC=CC=C1
    Inchi InChI=1S/C9H10O3/c1-12-9(8(10)11)7-5-3-2-4-6-7/h2-6,9H,1H3,(H,10,11)
    Usage Intermediate in pharmaceutical synthesis
    Hazard Statements Irritant to skin and eyes

    As an accredited Dl-Alpha-Methoxyphenylacetic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging is a sealed 100g amber glass bottle, labeled "DL-Alpha-Methoxyphenylacetic Acid," featuring hazard warnings and batch information.
    Shipping **Shipping for Dl-Alpha-Methoxyphenylacetic Acid:** This chemical should be shipped in tightly sealed containers, protected from moisture and incompatible materials. It must be appropriately labeled and packaged according to local, national, and international regulations, including hazard communication standards. Shipping should comply with relevant chemical transport guidelines, ensuring safe and secure transit to prevent spills or exposure.
    Storage Dl-Alpha-Methoxyphenylacetic Acid should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area away from direct sunlight and sources of heat or ignition. It should be kept away from incompatible materials such as strong oxidizers. Proper labeling and secondary containment are recommended to prevent contamination and ensure safe handling.
    Application of Dl-Alpha-Methoxyphenylacetic Acid

    Applications of Dl-Alpha-Methoxyphenylacetic Acid in Industrial Manufacturing

    As a direct manufacturer of Dl-Alpha-Methoxyphenylacetic Acid, we supply this specialty intermediate to enterprises engaged in diverse high-value chemical transformations. The following application scenarios summarize real-world industrial uses, formulation specifics, compliance frameworks, manufacturing processes, and the downstream finished goods produced by our clients.

    1. Non-Steroidal Anti-Inflammatory Drug (NSAID) Synthesis

    Pharmaceutical companies employ Dl-Alpha-Methoxyphenylacetic Acid as an essential intermediate in the synthesis of certain arylacetic acid-based NSAIDs. Our customers integrate this compound during the key condensation stage to construct the core pharmacophore, which undergoes subsequent modifications to yield active pharmaceutical ingredients (API). Usage requires regulatory traceability and tight compliance to pharmacopeial monographs throughout the synthesis, purification, and final API approval.

    Industry compliance standards

    • Current Good Manufacturing Practices (cGMP), ICH Q7
    • EU Guidelines for Good Manufacturing Practice for Medicinal Products
    • Relevant pharmacopeias: USP, Ph. Eur.
    • FDA 21 CFR Parts 210 and 211, drug substance regulations

    Typical usage ratio

    • 0.9–1.1 molar equivalents per target arylacetic acid derivative, adjusted according to desired phenyl ring and sidechain position; final weight percent in batch synthesis typically around 10–18% depending on the NSAID structure

    Downstream process integration

    • Added after Grignard or Friedel–Crafts acylation step; participates in core chain elongation and methylation in multi-step organic synthesis; final purification via crystallization, followed by API isolation in GMP-compliant facilities

    Final product types

    • Finished NSAID active pharmaceutical ingredients (e.g., certain ibuprofen analogs)
    • Pharmaceutical intermediates for regulated supply chains
    • Bulk API powder for export and formulation
    • Prescription-grade oral tablet and capsule products

    2. Chiral Building Block for Agrochemical Synthesis

    Agrochemical formulation plants utilize Dl-Alpha-Methoxyphenylacetic Acid as a precursor for synthesizing a select group of phenylacetic acid-derived herbicides, incorporating the methoxy functionality to improve selectivity and degradability. The material supports enantioselective synthesis of target molecules used in crop protection product actives and demands compliance with both chemical production safety and agricultural residue controls.

    Industry compliance standards

    • ISO 9001:2015 for quality management in chemical synthesis
    • REACH (EC 1907/2006), relating to registration and use of chemical substances in Europe
    • FAO/WHO Codex Alimentarius for pesticide residues
    • National standards for technical material purity (e.g., GB 28170-2020 in China)

    Typical usage ratio

    • 3–7% by mass in initial synthetic reactions, variable based on targeted herbicide molecular design, commonly scaled according to end-use concentrations in formulated products

    Downstream process integration

    • Introduced during stage 2 or 3 in multi-step catalytic synthesis for phenoxyacetic and other arylacetic acid-type herbicide actives; post-reaction mixture subjected to phase separation and further chlorination or etherification where required

    Final product types

    • Technical grade herbicide actives
    • Finished water-dispersible granules and suspension concentrates for sprayed application
    • Emulsifiable concentrate formulations for sale to regional agrochemical formulators
    • Chemical intermediates for pre-emergent weed management products

    3. Aroma Intermediate for Flavor and Fragrance Manufacturing

    Producers of aroma chemicals select Dl-Alpha-Methoxyphenylacetic Acid as a key intermediate to synthesize specific phenylacetic alcohols and ethers. These intermediates impart stable and nuanced top notes in fine fragrance compositions as well as food-grade flavorings. Process controls focus on compliance with food additive purity requirements and minimizing residual solvents as stipulated by regulatory agencies.

    Industry compliance standards

    • IFRA Code of Practice for fragrance ingredient traceability
    • Food Chemicals Codex (FCC) for flavor ingredient standards
    • 21 CFR 172 for FEMA GRAS flavor uses
    • ISO 9001:2015 for process and documentation control

    Typical usage ratio

    • 4–12% by weight in targeted aroma intermediate batch synthesis; concentration adjusted based on end odor note complexity and required purity for downstream coupling reactions

    Downstream process integration

    • Engaged during nucleophilic substitution and etherification steps to build specific aromatic profiles; isolated intermediates purified via fractional distillation or chromatographic separation prior to blending into fine fragrances and flavor mixes

    Final product types

    • Custom aroma intermediates for perfumery and personal care brands
    • Food-grade flavor enhancers for beverages and sweets
    • Ready-to-use fragrance compounds for soaps, detergents, and household cleaners
    • Bulk fragrance materials for blending in contract manufacturing environments

    4. Specialty Pharmaceutical Intermediate for Chiral Synthesis Programs

    Advanced pharmaceutical R&D and process development teams use Dl-Alpha-Methoxyphenylacetic Acid in asymmetric synthesis strategies designed to create enantiomerically enriched intermediates. This is critical in programs pursuing active molecules with high chiral purity and fine-tuned pharmacological profiles. Compliance with research chemical and pre-GMP pilot scale standards applies before full-scale regulatory manufacturing.

    Industry compliance standards

    • ISO 13485:2016 for medical R&D labs handling regulated substances
    • ICH Q11 on development and manufacturing of drug substances
    • Regulatory framework for advanced intermediates (as per regional drug authorities)
    • GMP for pilot-scale upscaling, where applicable

    Typical usage ratio

    • 0.5–2.5 equivalents per targeted chiral center in asymmetric induction reactions; ratio determined by catalyst/resin loading and desired stereochemical outcome, frequently validated by chiral HPLC analysis during process optimization

    Downstream process integration

    • Serves as the starting substrate or resolution agent; introduced during enantioselective hydrogenation, asymmetric alkylation, or resolution steps; final intermediate purified by preparative chromatography prior to further derivatization

    Final product types

    • Chiral pharmaceutical intermediates
    • Development-stage API candidates for clinical trials
    • Building blocks for advanced medicinal chemistry pipelines
    • Bulk supplied advanced intermediates for custom synthesis projects
    Free Quote

    Competitive Dl-Alpha-Methoxyphenylacetic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing Dl-Alpha-Methoxyphenylacetic Acid: A Perspective from Our Lab Floor

    What Our Team Has Learned from Decades with Dl-Alpha-Methoxyphenylacetic Acid

    Manufacturing Dl-Alpha-Methoxyphenylacetic Acid isn't just about reacting a list of chemicals and watching a machine do its job. In our facility, we make decisions every day based on years of direct experience with the behavior of this compound—how it crystallizes, its solubility in different solvents, and how subtle changes can deliver a batch that fits a customer’s precise needs. Our chemists know firsthand that this material, often referenced by its CAS number 3255-32-3 and with the model code DL-α-MPA, plays a role that’s central in several demanding applications, especially in pharmaceutical synthesis and specialty chemical production.

    We have always prioritized purity, because impurities in our alpha-methoxyphenylacetic acid can disrupt critical downstream reactions. Over the years, we’ve honed our processes to regularly provide material with purity levels exceeding 99% as measured by HPLC. Sometimes clients on the pharmaceutical synthesis side require an even tighter profile, looking specifically for low levels of water and residual solvents. Our facility is equipped with drying and purification systems that allow us to tailor specifications for each requirement, but for most uses, the standard fine white crystalline powder we supply fits the bill.

    Real-World Applications: Why Our Partners Count on Consistency

    Those who buy Dl-Alpha-Methoxyphenylacetic Acid are not simply looking for any fine powder—they need reliable performance batch after batch. This material shows up in numerous advanced syntheses. Our customers most often use it as a versatile building block in the development of phenylacetic acid derivatives. In pharmaceutical projects, it’s part of the process leading to non-steroidal anti-inflammatory agents, and sometimes to intermediates for certain beta-lactam antibiotics. The ester and amide derivatives that come from this acid are important in several reactions that demand precision.

    Consistency in melting point (typically 75-78°C in our batches), particle size, and trace chemical profile makes it possible for R&D teams to repeat their results and for production lines to avoid interruptions. On more than one occasion, we’ve seen partners frustrated by off-grade batches from other sources—problems ranging from trace contaminants to color and odor variations. They come to us looking for solutions that let them get back to delivering their own products with confidence. We have learned that even a mild deviation in quality can cause multi-stage synthesis processes to drag or misfire.

    From Sourcing to Delivery: Why Controls Matter

    We start with reliable sources for all feedstock. Each drum, each container entering our synthesis area undergoes rigorous testing. Taking pride in controlling every aspect—from raw material prep to final packaging—means we ship nothing untested or undocumented. Even with a compound as familiar as Dl-Alpha-Methoxyphenylacetic Acid, we’ve seen that the quality of upstream materials, solvent selection, and temperature curve during reaction all shape the final result. Our analytics lab runs every batch through GC (gas chromatography), HPLC, IR (infrared spectroscopy), and often NMR for full traceability. The result is not just a product specification sheet but a material with a documented and monitored history.

    Handling of this acid requires sensible safety practices. It’s not especially hazardous by the standards of specialty organics, but years of hands-on work have shown us how dust control, proper containment, and operator training make day-to-day processing safer and smoother. Because much of our end product travels internationally, we use tamper-evident sealing and certified containers for each shipment.

    Why Choose the DL Form: Key Differences and Outcomes

    We frequently get questions about the differences between DL-Alpha-Methoxyphenylacetic Acid and its optical isomers. In practical lab and industrial settings, we’ve seen most customers prefer the racemic DL- form for synthetic chemistry, especially where chiral effects downstream aren’t a concern or when racemization will occur later anyway. The L- and D- forms, when separated, address special needs in enantioselective syntheses—a field where absolute control over stereochemistry makes the difference between success and failure. Producing the pure L- or D- enantiomer demands extra steps and dramatically raises costs, so the DL form often offers the best combination of affordability and reactivity for pilot and scale-up projects.

    Those with requirements for asymmetric synthesis or biologically active compounds that depend on chirality often require a different approach, sometimes using our DL material as a precursor for later chiral resolution. We’ve collaborated with academic and commercial partners to deliver both racemic and optically pure forms at different stages of development. Being a manufacturer, not a trader, gives us leverage to tweak and troubleshoot at any point in the process, a flexibility that third-parties rarely provide.

    Addressing the Demands of Scale and Customization

    Scaling up from bench-scale trials to full production requires more than just bigger equipment. Each jump in size brings its own surprises. Our plant managers and chemical engineers often revisit recipes for each production run, checking everything from mixing rate to temperature gradients. Dl-Alpha-Methoxyphenylacetic Acid isn’t especially fussy, but we’ve noticed that even minor changes in reactor geometry or cooling rates can alter the outcome. Lab-bench results can look great, but translating that to bulk production takes skill, adjustment, and experience.

    Over the years, some clients have asked for coarser material or for specific packaging formats—double-layered bags, small-volume jars for R&D, or large fiber drums for manufacturing. We maintain a flexible bottling and repacking system to meet these needs, while keeping documentation consistent. This adaptability, combined with transparent QC data, has convinced long-term partners to rely on us rather than take risks with resellers whose supply chains add complexity and sometimes confusion.

    Supporting the People Behind Every Synthesis

    Talking with project chemists and plant managers, we recognize the constant pressure to deliver reliable results. Material cost plays a role, but wasted time or lost batches hurt far more. Our own staff have run countless test reactions using our in-house DL-Alpha-Methoxyphenylacetic Acid, examining reaction times, yields, and ease of purification. We never simply chase specification checkboxes. Instead, we ask: does each batch perform as expected across reaction scales and conditions? When we notice something off—whether in solubility, handling, or reactivity—we act before shipping even a kilo.

    Feedback from pharmaceutical process engineers and specialty manufacturers has pushed us to tighten our internal standards. In the past, some batches from external sources showed yellowing or small amounts of methanol residue. This caused headaches for end-users in sensitive applications, especially where final products must meet strict regulations for APIs or research-grade intermediates. Eliminating these issues meant investing in analytics and improving our purification routes. We know from direct experience how a small tweak—an extra filtration step, a revised reflux schedule—can pay off for our partners down the line.

    Documenting Transparency: Data’s Role in Trust

    Delivering material with accompanied COAs and analytics reports isn’t just a formality. We’ve found that open records mean fewer quality disputes and speedier clearances through incoming inspections at customer facilities. Our documentation includes test results for moisture content, key impurity levels, and exact assay percentages. Clients have cited our records as a deciding factor when switching from anonymous market sources to a dedicated manufacturer. Beyond paperwork, we’re always available for discussion: whether it’s a question on storage recommendations or advice for specific downstream chemistry, our technical staff share the experience that comes from daily hands-on production.

    On occasion, we’ve faced unusual requests—a batch with lower moisture for a water-sensitive custom synthesis, or a sample lot produced using alternative solvents to test downstream compatibility. Experience has taught us to weigh every request carefully before responding. There’s no substitute for a manufacturer’s agility when a project hits an obstacle and needs an uncommon variation. Our R&D unit steps in with bench trials and pilot runs, making sure nothing sent to the customer is experimental or compromised.

    Comparison with Similar Materials

    Many of our customers compare Dl-Alpha-Methoxyphenylacetic Acid directly with related aromatic acids and their derivatives. For example, methoxy-substituted acetic acids are often assessed alongside unsubstituted phenylacetic acid or compounds with alkyl rather than methoxy groups. Over hundreds of syntheses in our pilot plant and through external partner feedback, a few clear differences have emerged.

    The methoxy group on the alpha position provides unique reactivity. Compared with phenylacetic acid itself, our material shows increased solubility in certain polar and nonpolar solvents. This can speed up reaction rates or simplify purification steps, especially important when time and production cost are both competing priorities. We’ve found that substitutions on the aromatic ring or side chain often change everything from melting point to product yield. This makes choosing the right intermediate more than just a theoretical concern—it’s a decision that can improve efficiency and final compound properties.

    Some partners reach out for material with narrower melting points or ask how our acid compares with other functionalized arylacetic acids in performance. We draw from actual run data and customer feedback, not just literature references or catalog entries. Dl-Alpha-Methoxyphenylacetic Acid frequently becomes the workhorse intermediate for chemo-selective modifications that more common acids simply can’t support. Our experience has shown that the methoxy-substituted version often tolerates harsher conditions and delivers higher product purity, especially in esterification and amide formation sequences.

    Pushing for Continuous Improvement

    We do not take established processes for granted. Our plant runs regular improvement cycles. Whether it’s a small upgrade to a crystallization vessel or redesigning parts of the plant for energy savings, our staff tracks every variable. It pays off in more stable batches and fewer customer questions about process changes or off-spec material. This discipline also means we can adapt quickly when a research partner appears with new requirements—tighter particle size cutoff, lower transition metal content, or different packaging to suit automated dispensing lines.

    Because we handle other arylacetic acids and related building blocks, our staff routinely compares how each material reacts, purifies, and stores under parallel conditions. Dl-Alpha-Methoxyphenylacetic Acid stands out in handling convenience and shelf stability. Careful attention to residual solvent levels and packaging ensures performance through even long-term storage, another expectation shared by high-throughput users and specialty formulators alike.

    Supporting Transparency and Traceability Across Borders

    Increasing international regulatory demands have changed how we document and ship specialty chemicals, including Dl-Alpha-Methoxyphenylacetic Acid. Customs, end-user declarations, and material origin certifications are now part of regular business. We assist partners in navigating these requirements by providing complete chain-of-custody and traceability data for every lot shipped.

    From our vantage point, transparency has gone from a “nice to have” to an absolute necessity. Experience with customs audits and regulatory reviews shows us how missing paperwork or incomplete batch traceability can delay, or even halt, entire projects. Our paperwork matches every lot to its date code, production report, and shipment ID, so customers are never guessing where their material came from or how it was made.

    Looking Ahead: Where We See Opportunity with Dl-Alpha-Methoxyphenylacetic Acid

    Our own R&D teams continue to explore niche uses for this compound. Recent projects include its application in chiral auxiliary synthesis, designer monomers for specialty polymers, and as a starting material for agrochemical research. Emerging interest in the fine chemicals sector has led us to trial smaller batches for boutique applications, such as fragrance intermediates. Every new project sharpens our expertise and deepens our understanding of how DL-Alpha-Methoxyphenylacetic Acid interacts under different process conditions.

    Collaboration remains our most valuable asset. Whether working with established pharmaceutical giants or startup teams tinkering with greener reaction conditions, we draw on a foundation of hands-on chemical manufacturing. This direct line of communication—chemist to chemist, operator to operator—allows us to deliver beyond the specification sheets and into the real-world challenges faced in fine chemical production every day.

    Final Thoughts from a Manufacturer’s Viewpoint

    Dl-Alpha-Methoxyphenylacetic Acid is more than just a chemical entry or a line item in a catalog. It represents years of accumulated expertise, thousands of hours of direct handling, and a continuous push for better outcomes in terms of purity, performance, and reliability. By manufacturing at scale in a controlled environment, continuously improving based on feedback, and maintaining transparency at every step, we give our partners the confidence to focus on their own breakthroughs.

    Each drum, each jar, each kilogram handed over has a backstory shaped by real chemists driving for better reactions, smoother processes, and repeatable results. We view Dl-Alpha-Methoxyphenylacetic Acid not only as a product but as a reflection of how intelligent manufacturing and close client relationships combine to keep projects moving forward. It’s that boots-on-the-floor experience, hard data, and shared technical dialogue that set us apart and create long-term value for every customer, across every industry where this uncommon acid finds its place.